PCSK6 and posterior cortical atrophy: On the other hand, the tight correlation of the PACE4-altCT overexpression and the tumor Gleason score (indicating aggressive malignancy) has been demonstrated11, strengthening the position of PACE4 as a new target for therapeutic drug development for PCa.